Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents-Reference-Cited by-同舟云学术

Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents

Published:1993-01 Issue:14 Volume:29 Page:2009-2014
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Vogel M,Hilsenbeck S.G,Depenbrock H,Danhauser-Riedl S,Block T,Nekarda H,Fellbaum Ch,Aapro M.S,Bissery M.C,Rastetter J,Hanauske A.-R

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Experimental properties of RP 56976, a taxol derivative;Lavelle,1989

2. New natural products in cancer chemotherapy;Slichenmyer;J Clin Pharmacol,1990

3. The chemistry of taxol;Kingston;Pharmacol Ther,1991

4. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol;Ringel;J Natl Cancer Inst,1991

5. Mechanism of action of taxol;Horwitz;Trends Pharmacol Sci,1992

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel view of the separate and simultaneous binding effects of docetaxel and anastrozole with calf thymus DNA: Experimental and in silico approaches;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2020-03

2. Taxane resistance in breast cancer: A closed HER2 circuit?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2012-04

3. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer;Cancer Biology & Therapy;2010-01

4. Docetaxel;Drug Management of Prostate Cancer;2010

5. Docetaxel in the management of prostate cancer: current standard of care and future directions;EXPERT OPIN PHARMACO;2008